CL
IDXX icon

Choreo LLC’s Idexx Laboratories IDXX Stock Holding History

Choreo LLC’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
2,125
+95
+5% +$53.3K 0.01% 602
2026
Q1 		$1.14M Buy
2,030
+36
+2% +$23.1K 0.01% 567
2025
Q4 		$1.36M Sell
1,994
-672
-25% -$458K 0.02% 488
2025
Q3 		$1.7M Sell
2,666
-21
-0.8% -$12.7K 0.02% 410
2025
Q2 		$1.44M Buy
2,687
+1,143
+74% +$547K 0.02% 455
2025
Q1 		$648K Buy
1,544
+64
+4% +$27.8K 0.01% 717
2024
Q4 		$611K Sell
1,480
-476
-24% -$209K 0.01% 798
2024
Q3 		$969K Sell
1,956
-613
-24% -$298K 0.01% 585
2024
Q2 		$1.23M Buy
+2,569
New +$1.29M 0.02% 447
2015
Q2 		– Sell
-3,000
Closed -$232K – 155
2015
Q1 		$232K Hold
3,000
– – 0.06% 132
2014
Q4 		$222K Buy
+3,000
New +$210K 0.06% 135
2014
Q3 		– Sell
-3,000
Closed -$200K – 151
2014
Q2 		$200K Buy
+3,000
New +$191K 0.06% 142

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Choreo LLC's IDXX Position: Q2 2026 in Review

Choreo LLC increased its Idexx Laboratories (IDXX) stake by 4.7% in Q2 2026, buying an estimated $53.3K and bringing the position to 2,125 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #602.

Choreo LLC first reported a position in IDXX in Q2 2014 and has held it in 12 quarters since. The position peaked at $1.7M in Q3 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Choreo LLC held 2,125 shares of Idexx Laboratories worth $1.12M as of Q2 2026.
  • Choreo LLC bought 95 Idexx Laboratories shares in Q2 2026, an estimated $53.3K.
  • Idexx Laboratories made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #602 holding.
  • Choreo LLC first reported a position in Idexx Laboratories in Q2 2014 and has held it in 12 quarters since.
  • Choreo LLC's Idexx Laboratories position peaked at $1.7M in Q3 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.